Expanesthetics is developing new and better analgesics and general anesthetics.

About Us

We are addressing the opioid crisis in America and the vast unmet medical needs in pain management by developing a new class of pain drugs that was discovered by accident during our search for new and better general anesthetics. We are also working to reduce anesthetic costs and bring general anesthesia to the third of the world that lacks access through the development of new and better agents.

Our Pipeline

Expanesthetics Team

Expanesthetics is a preclinical-stage, technology-enabled small molecule pharmaceutical company with disruptive programs in analgesia and general anesthesia.

Featured News

Expanesthetics Spotlighted by Leading Research University

Founded in 2012, Expanesthetics is tackling one of the longest-standing scientific questions in modern medicine: How do general anesthetics work? The company's goal is to expand the choice of anesthetic agents available for clinical use in order to improve patient outcomes and reduce costs. This story tells some of Expanesthetics' history and progress to-date.